Oral chemotherapy raises hope for stomach cancer patients
A combination of low dose tablets taken orally promises to be not just a cost effective chemotherapy but is showing positive results in survival rate.
GASTRIC CANCER
-
Evidence of CAR T-cell therapy against cancers presented at US conference
A phase-1 trial primarily looks at establishing a new drug's safety and dose characteristics in about 20-100 healthy volunteers, while a 'phase-2' trial provides evidence of the effectiveness of the experimental drug in about 100-300 volunteers or participants.
-
Agilus introduces Claudin 18.2 test for precise cancer diagnosis
-
BeiGene's gastric cancer drug succeeds in late-stage trial
-
Minimally Invasive Robotic and Laparoscopic Gastrectomy: A new ray of hope for gastric cancer
-
Why early diagnosis remains the best bet in fighting gastric cancer
-
Why early diagnosis remains the best bet in fighting gastric cancer
-
Why early diagnosis remains the best bet in fighting gastric cancer
-
Natco Pharma launches novel fixed-dose combination drug for colorectal, gastric cancer
-
'Potential gastric cancer biomarker identified'
Advertisement
More in GASTRIC CANCER
-
-
Watch what you eat: 40 is new 60 for gastric cancer
Being young does not mean being healthy these days. Changing lifestyles, work stress and junk food at odd hours take a toll rather early.
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
